Genmab CEO: Three products may turn into five this year
Normally, it takes ten months for a marketing authorization to be processed in the US. Genmab hopes for an accelerated process, so the firm can get approval for two new products this year.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Genmab's three winning horses may very well turn into five in the course of 2021.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Genmab CEO: Arbitration might be concluded in 2021
For subscribers
